Standout Papers

Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinas... 2001 2026 2009 2017 821
  1. Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies (2001)
    Manuel Hidalgo, Lillian L. Siu et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 20 from Science/Nature 99 standout
Sub-graph 1 of 17

Citing Papers

Sulfenylnitrene-mediated nitrogen-atom insertion for late-stage skeletal editing of N -heterocycles
2025 StandoutScience
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
2 intermediate papers

Works of Karen J. Ferrante being referenced

Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies
2001 Standout

Author Peers

Author Last Decade Papers Cites
Karen J. Ferrante 734 853 355 18 1.2k
V. Damiano 561 791 497 31 1.3k
J.R. Woodburn 607 940 688 14 1.7k
Shailaja Kalyankrishna 575 700 687 9 1.3k
Haitian Quan 375 651 485 30 1.3k
G Pomatico 616 973 584 8 1.4k
Lisa O’Rourke 462 964 294 29 1.4k
Emily Dunn 482 858 739 24 1.7k
Robert Millham 327 789 628 20 1.6k
Didier Verhoeven 685 834 379 38 1.4k
Roberta Caputo 633 773 587 26 1.3k

All Works

Loading papers...

Rankless by CCL
2026